Bristol-Myers Squibb wins antitrust approval to buy Celgene on condition it sell psoriasis drug

FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau WASHINGTON (Reuters) - Bristol-Myers Squibb Co (BMY.N) ....

Continue reading
Show Buttons
Hide Buttons